Company: THC
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001193125-25-079143
Chunk: 47

Company: TENET HEALTHCARE CORP
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 47
---
 influence on Company culture, which further the Company’s business objectives and strategies. The result is an individual performance multiplier applied to the calculated AIP amount that can range from 0% to 150%. The ratings are calibrated across the entire Company to ensure the AIP funding pool remains fixed.

| 52 |

Compensation Discussion & Analysis For the Chairman and CEO, the HR Committee gathers feedback from select members of management and discusses the performance of the officer with the other independent members of the Board in executive session. For reviews of other executive officers, the Chairman and CEO provides the HR Committee a detailed evaluation and recommendation based in part on a self-assessment completed by each executive officer. The HR Committee applied the following performance modifiers for our NEOs based on the material factors provided below.

| Named Executive Officer |     | Individual  
 Performance 
 Multiplier  |     |      |     | Performance Review Summary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Dr. Sutaria             |     |             |     | 150% |     | •  Continued to drive key strategic and operating goals as part of the Company’s continuing transformative growth strategy   •  Led delivery of continued strong financial and operating performance through sustained data-driven, disciplined management and strong operational execution   •  Continued to strengthen the Company’s leadership team to drive a high-performance culture committed to quality, safety and compliance                                                                                                                                                                                                                |
| Mr. Park                |     |             |     | 110% |     | •  Led the continued strengthening of finance talent, systems, and processes to support the growth and portfolio transformation of the Company   •  Continued to strengthen the liquidity and capital structure of the Company through disciplined capital allocation, cashflow management, and retirement of debt   •  Provided leadership in achievement of the Company’s 2024 Adjusted EBITDA and Adjusted Free Cash Flow budgeted targets and demonstrated strong growth in 2024 financial results over the prior year                                                                                                                            |
| Mr. Arnst               |     |             |     | 150% |     | •  Continued to lead the strengthening of our legal and human resources teams to further optimize performance and results   •  Drove the ongoing streamlining of our legal and human resources functions as part of our continuing enterprise service delivery model and external spend cost management   •  Championed the continuing shift of service functions to the GBC with over 4,